Literature DB >> 8824574

Human T cells expressing an invariant V alpha 24-J alpha Q TCR alpha are CD4- and heterogeneous with respect to TCR beta expression.

S Porcelli1, D Gerdes, A M Fertig, S P Balk.   

Abstract

A population of mature CD4-CD8-double-negative T cells that expresses an invariant Valpha24-JalphaQ TCR has been identified in humans; the majority of these cells appear to express Vbeta11. A closely related in variant TCRalpha chain is also expressed by a population of NK1+ murine T cells, but these cells may be either CD4+ or double negative. In this report, multiple CD4+ or double-negative Valpha24+Vbeta11+ T-cell clones were isolated, and only the double-negative clones were found to express the invariant TCRalpha chain. Studies of TCRbeta chains expressed by these cells demonstrate that a subset in some donors use Vbeta genes other than Vbeta11. Characterization of Vbeta11 TCRs in one donor by CDR3-length analysis was also carried out. The results indicate that multiple Vbeta11 TCRs of differing CDR3 lengths may associate with the invariant TCRalpha chain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824574     DOI: 10.1016/0198-8859(96)00090-0

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  23 in total

1.  CD1d and invariant NKT cells at the human maternal-fetal interface.

Authors:  Jonathan E Boyson; Basya Rybalov; Louise A Koopman; Mark Exley; Steven P Balk; Frederick K Racke; Frederick Schatz; Rachel Masch; S Brian Wilson; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

Review 2.  The innate immune system and HIV pathogenesis.

Authors:  Karla A Eger; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2005-02       Impact factor: 5.071

3.  Adoptive immunotherapy mediated by ex vivo expanded natural killer T cells against CD1d-expressing lymphoid neoplasms.

Authors:  Davide Bagnara; Adalberto Ibatici; Mirko Corselli; Nadia Sessarego; Claudya Tenca; Amleto De Santanna; Andrea Mazzarello; Antonio Daga; Renzo Corvò; Giulio De Rossi; Francesco Frassoni; Ermanno Ciccone; Franco Fais
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

Review 4.  NKT cells at the maternal-fetal interface.

Authors:  J E Boyson; I Aktan; D A Barkhuff; A Chant
Journal:  Immunol Invest       Date:  2008       Impact factor: 3.657

5.  Characterization of human invariant natural killer T cells expressing FoxP3.

Authors:  Péter Engelmann; Klára Farkas; János Kis; Geoffrey Richman; Zhaoyun Zhang; Chong Wee Liew; Maciej Borowiec; Monika A Niewczas; Heyam Jalahej; Tihamér Orbán
Journal:  Int Immunol       Date:  2011-06-27       Impact factor: 4.823

Review 6.  Glycolipid targets of CD1-mediated T-cell responses.

Authors:  D B Moody; G S Besra
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

Review 7.  Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma.

Authors:  Seddon Y Thomas; Yung H Chyung; Andrew D Luster
Journal:  J Allergy Clin Immunol       Date:  2010-03-20       Impact factor: 10.793

Review 8.  Activation strategies for invariant natural killer T cells.

Authors:  Ayano C Kohlgruber; Carlos A Donado; Nelson M LaMarche; Michael B Brenner; Patrick J Brennan
Journal:  Immunogenetics       Date:  2016-07-25       Impact factor: 2.846

9.  CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccines.

Authors:  Kamal U Saikh; Beverly Dyas; Teri Kissner; Robert G Ulrich
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvants.

Authors:  Priyanka Subrahmanyam; Tonya J Webb
Journal:  Front Biol (Beijing)       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.